Abstract and Introduction Abstract Epidermolysis bullosa (EB) encompasses a heterogeneous group of inherited skin fragility disorders, with mutations in genes encoding the basement membrane zone (BMZ) proteins that normally ensure dermal–epidermal integrity.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by J.a. McGrath
The potential of gene therapy for recessive dystrophic epidermolysis bullosa
REVIEW ARTICLE K.S. Subramaniam, Genetic Skin Diseases Group, St John’s Institute of Dermatology, King’s College London, Guy’s Hospital, London, UK Search for more papers by this author M.N. Antoniou, Gene Expression and Therapy Group, Department of Medical & Molecular Genetics, King's College London, Guy's Hospital, London, UK Search for more papers by this author J.A. McGrath, Genetic Skin Diseases Group, St John’s Institute of Dermatology, King’s College London, Guy’s Hospital, London, UK...
WNT10A, dermatology and dentistry
REVIEW ARTICLE B.J. Doolan, orcid.org/0000-0002-9497-0504 St John's Institute of Dermatology, School of Basic and Medical Biosciences, King's College London, London, United Kingdom Contribution: Data curation (lead), Formal analysis (equal), Methodology (lead), Writing - original draft (lead), Writing - review & editing (equal) Search for more papers by this author A.
Immune tolerance of allogeneic haematopoietic cell transplantation supports donor epidermal grafting of recessive dystrophic epidermolysis bullosa chronic wounds*
MEDICAL DERMATOLOGY C.L. Ebens, Corresponding Author ebens012@umn.edu orcid.org/0000-0003-2430-911X Division of Blood and Marrow Transplantation, Department of Pediatrics, Medical School, University of Minnesota, Minneapolis, MN, USA Correspondence Christen L. Ebens.
Heterogeneous addiction to transforming growth factor‐beta signalling in recessive dystrophic epidermolysis bullosa‐associated cutaneous squamous cell carcinoma*
Translational research J.H.S. Dayal Cancer Research UK Beatson Institute, Glasgow, UK Division of Cancer Research, Ninewells Hospital and Medical School, Jacqui Wood Cancer Centre, University of Dundee, Dundee, UK Contribution: Conceptualization (equal), Data curation (lead), Formal analysis (lead), Investigation (lead), Methodology (lead), Project administration (equal), Writing - original draft (lead), Writing - review & editing (equal) Search for more papers by this author R.G. Taylor...
A decade of next‐generation sequencing in genodermatoses: the impact on gene discovery and clinical diagnostics*
Summary Background Discovering the genetic basis of inherited skin diseases is fundamental to improving diagnostic accuracy and genetic counselling. In the 1990s and 2000s, genetic linkage and candidate gene approaches led to the molecular characterization of several dozen genodermatoses, but over the past decade the advent of next‐generation sequencing (NGS) technologies has accelerated diagnostic discovery and precision.
Mutations in genes encoding desmosomal proteins: spectrum of cutaneous and extracutaneous abnormalities*
Summary The desmosome is a type of intercellular junction found in epithelial cells, cardiomyocytes and other specialized cell types. Composed of a network of transmembranous cadherins and intracellular armadillo, plakin and other proteins, desmosomes contribute to cell–cell adhesion, signalling, development and differentiation. Mutations in genes encoding desmosomal proteins result in a spectrum of erosive skin and mucosal phenotypes that also may affect hair or heart.
Alopecia areata and frontal fibrosing alopecia: dimorphism by concurrence
CORRESPONDENCE S.M. McSweeney Corresponding Author E-mail address: sheila.mcsweeney@kcl.ac.uk St. John’s Institute of Dermatology, Guy’s Hospital, Great Maze Pond, London, SE1 9RT United Kingdom Correspondence Sheila McSweeney Email: sheila.mcsweeney@kcl.ac.uk Search for more papers by this author This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to...
用于 RDEB 的 PTCy BMT
Summary 泛发型重度隐性营养不良性大疱性表皮松解症 (RDEB‐GS) 是一种罕见的不可治愈的遗传疾病,此疾病患者皮肤的主要成分 7 型胶原 (C7) 出现缺陷或缺失。 由此导致皮肤和粘膜与身体脱离,引发水疱和伤口。骨髓移植 (BMT) 可恢复皮肤中的 C7,其机理很可能是提供可转变为健康新皮肤细胞的间充质干细胞 (MSC)。但是,BMT 是一种存在风险的不适操作,因为需要用药来阻止患者免疫系统排斥捐献的骨髓,而这些药物本身可能导致疾病,有时甚至致死。移植组织中的免疫细胞甚至可能攻击患者,导致移植物抗宿主疾病 (GvHD)。 这些明尼苏达州立大学的医生们在 10 名 RDEB‐GS 儿童中尝试了一种不同的 BMT 方案,该方案使用较低强度的移植前免疫抑制。移植后 3 天,向他们给用称为环磷酰胺 (PTCy) 的免疫抑制药物。2 个月后,当患者身体已经接受供体组织时,他们可以从相同供体接受更多 MSC。 此移植在 3 名患者中失败,其中 2 名经历了重复的 BMT,1 名发生了严重并发症,并在 1 年后死亡。移植成功患者在皮肤活检中显示了 C7...
PTCy BMT for RDEB
Summary Generalised severe recessive dystrophic epidermolysis bullosa (RDEB‐GS) is a rare, incurable genetic disorder in which an essential skin component, type 7 collagen (C7), is defective or missing. As a result, skin and mucous membranes detach from the body, causing blisters and wounds. Bone marrow transplantation (BMT) can restore C7 in the skin, probably by supplying mesenchymal stem cells (MSCs) which turn into healthy new skin cells.
PADI3, hair disorders and genomic investigation
Editorial J.A. McGrath Corresponding Author E-mail address: john.mcgrath@kcl.ac.uk St John's Institute of Dermatology, King's College London (Guy's Campus), London, U.K. Search for more papers by this author PDF PDF Share Get access to the full version of this article.View access options below. If you have previously obtained access with your personal account, Please log in. No abstract is available for this article.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with J.a.
Contact J.a., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack